ArriVent BioPharma
AVBP
AVBP
83 hedge funds and large institutions have $539M invested in ArriVent BioPharma in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+3
Holders Change %
+3.75%
% of All Funds
1.13%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
15
Increased
29
Reduced
22
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IAM
Infinitum Asset Management
Fort Lauderdale,
Florida
|
+$7.81M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$6.5M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.39M |
| 4 |
Millennium Management
New York
|
+$1.95M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.69M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.6M |
| 2 |
Goldman Sachs
New York
|
-$2.41M |
| 3 |
State Street
Boston,
Massachusetts
|
-$857K |
| 4 |
Morgan Stanley
New York
|
-$493K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$414K |
